Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Low-dose valganciclovir prohylaxis is efficacious and safe in cytomegalovirus seropositive heart transplant recipients with anti-thymocyte globulin.

Eriksson M, Jokinen JJ, Söderlund S, Hämmäinen P, Lommi J, Lemström K.

Transpl Infect Dis. 2018 Mar 7:e12868. doi: 10.1111/tid.12868. [Epub ahead of print]

PMID:
29512249
2.

An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans.

Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Räsänen SM, Lee S, Mancina RM, Bergentall M, Pietiläinen KH, Söderlund S, Matikainen N, Ståhlman M, Bergh PO, Adiels M, Piening BD, Granér M, Lundbom N, Williams KJ, Romeo S, Nielsen J, Snyder M, Uhlén M, Bergström G, Perkins R, Marschall HU, Bäckhed F, Taskinen MR, Borén J.

Cell Metab. 2018 Mar 6;27(3):559-571.e5. doi: 10.1016/j.cmet.2018.01.005. Epub 2018 Feb 15.

PMID:
29456073
3.

Family-specific aggregation of lipid GWAS variants confers the susceptibility to familial hypercholesterolemia in a large Austrian family.

Nikkola E, Ko A, Alvarez M, Cantor RM, Garske K, Kim E, Gee S, Rodriguez A, Muxel R, Matikainen N, Söderlund S, Motazacker MM, Borén J, Lamina C, Kronenberg F, Schneider WJ, Palotie A, Laakso M, Taskinen MR, Pajukanta P.

Atherosclerosis. 2017 Sep;264:58-66. doi: 10.1016/j.atherosclerosis.2017.07.024. Epub 2017 Jul 22.

PMID:
28772107
4.

Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity.

Taskinen MR, Söderlund S, Bogl LH, Hakkarainen A, Matikainen N, Pietiläinen KH, Räsänen S, Lundbom N, Björnson E, Eliasson B, Mancina RM, Romeo S, Alméras N, Pepa GD, Vetrani C, Prinster A, Annuzzi G, Rivellese A, Després JP, Borén J.

J Intern Med. 2017 Aug;282(2):187-201. doi: 10.1111/joim.12632. Epub 2017 Jun 27.

PMID:
28548281
5.

Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.

Matikainen N, Söderlund S, Björnson E, Bogl LH, Pietiläinen KH, Hakkarainen A, Lundbom N, Eliasson B, Räsänen SM, Rivellese A, Patti L, Prinster A, Riccardi G, Després JP, Alméras N, Holst JJ, Deacon CF, Borén J, Taskinen MR.

Nutr Metab Cardiovasc Dis. 2017 Jun;27(6):534-542. doi: 10.1016/j.numecd.2017.03.003. Epub 2017 Mar 18.

PMID:
28428027
6.

Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.

Mardinoglu A, Bjornson E, Zhang C, Klevstig M, Söderlund S, Ståhlman M, Adiels M, Hakkarainen A, Lundbom N, Kilicarslan M, Hallström BM, Lundbom J, Vergès B, Barrett PH, Watts GF, Serlie MJ, Nielsen J, Uhlén M, Smith U, Marschall HU, Taskinen MR, Boren J.

Mol Syst Biol. 2017 Mar 2;13(3):916. doi: 10.15252/msb.20167422.

7.

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, Markevärn B, Själander A, Lotfi K, Dreimane A, Lübking A, Holm E, Björeman M, Lehmann S, Stenke L, Ohm L, Gedde-Dahl T, Majeed W, Ehrencrona H, Koskela S, Saussele S, Mahon FX, Porkka K, Hjorth-Hansen H, Bryceson YT, Richter J, Mustjoki S.

Leukemia. 2017 May;31(5):1108-1116. doi: 10.1038/leu.2016.360. Epub 2016 Nov 28.

8.

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli.

Söderlund S, Christiansson L, Persson I, Hjorth-Hansen H, Richter J, Simonsson B, Mustjoki S, Olsson-Strömberg U, Loskog A.

Leuk Res. 2016 Nov;50:95-103. doi: 10.1016/j.leukres.2016.09.019. Epub 2016 Sep 27.

PMID:
27710869
9.

Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.

Söderlund S, Dahlén T, Sandin F, Olsson-Strömberg U, Creignou M, Dreimane A, Lübking A, Markevärn B, Själander A, Wadenvik H, Stenke L, Richter J, Höglund M.

Eur J Haematol. 2017 Jan;98(1):57-66. doi: 10.1111/ejh.12785. Epub 2016 Aug 19.

PMID:
27428357
10.

The Contribution of GWAS Loci in Familial Dyslipidemias.

Ripatti P, Rämö JT, Söderlund S, Surakka I, Matikainen N, Pirinen M, Pajukanta P, Sarin AP, Service SK, Laurila PP, Ehnholm C, Salomaa V, Wilson RK, Palotie A, Freimer NB, Taskinen MR, Ripatti S.

PLoS Genet. 2016 May 26;12(5):e1006078. doi: 10.1371/journal.pgen.1006078. eCollection 2016 May.

11.

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity.

Vergès B, Adiels M, Boren J, Barrett PH, Watts GF, Chan D, Duvillard L, Söderlund S, Matikainen N, Kahri J, Lundbom N, Lundbom J, Hakkarainen A, Aho S, Simoneau-Robin I, Taskinen MR.

J Clin Endocrinol Metab. 2016 Apr;101(4):1398-406. doi: 10.1210/jc.2015-3740. Epub 2016 Feb 2.

PMID:
26835543
12.

Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.

Matikainen N, Björnson E, Söderlund S, Borén C, Eliasson B, Pietiläinen KH, Bogl LH, Hakkarainen A, Lundbom N, Rivellese A, Riccardi G, Després JP, Alméras N, Holst JJ, Deacon CF, Borén J, Taskinen MR.

PLoS One. 2016 Jan 11;11(1):e0145890. doi: 10.1371/journal.pone.0145890. eCollection 2016.

13.

In Vivo Cytochrome P450 3A Isoenzyme Activity and Pharmacokinetics of Imatinib in Relation to Therapeutic Outcome in Patients With Chronic Myeloid Leukemia.

Skoglund K, Richter J, Olsson-Strömberg U, Bergquist J, Aluthgedara W, Ubhayasekera SJ, Vikingsson S, Svedberg A, Söderlund S, Sandstedt A, Johnsson A, Aagesen J, Alsenhed J, Hägg S, Peterson C, Lotfi K, Gréen H.

Ther Drug Monit. 2016 Apr;38(2):230-8. doi: 10.1097/FTD.0000000000000268.

14.

Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal Obesity: Multicenter Tracer Kinetic Study.

Borén J, Watts GF, Adiels M, Söderlund S, Chan DC, Hakkarainen A, Lundbom N, Matikainen N, Kahri J, Vergès B, Barrett PH, Taskinen MR.

Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2218-24. doi: 10.1161/ATVBAHA.115.305614. Epub 2015 Aug 27. Erratum in: Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):e57.

15.

Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant.

Mancina RM, Matikainen N, Maglio C, Söderlund S, Lundbom N, Hakkarainen A, Rametta R, Mozzi E, Fargion S, Valenti L, Romeo S, Taskinen MR, Borén J.

J Clin Endocrinol Metab. 2015 May;100(5):E821-5. doi: 10.1210/jc.2014-4464. Epub 2015 Mar 12.

PMID:
25763607
16.

The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses.

Christiansson L, Söderlund S, Mangsbo S, Hjorth-Hansen H, Höglund M, Markevärn B, Richter J, Stenke L, Mustjoki S, Loskog A, Olsson-Strömberg U.

Mol Cancer Ther. 2015 May;14(5):1181-91. doi: 10.1158/1535-7163.MCT-14-0849. Epub 2015 Mar 11.

17.

Promoting health in virtual worlds: lessons from second life.

Suomi R, Mäntymäki M, Söderlund S.

J Med Internet Res. 2014 Oct 13;16(10):e229. doi: 10.2196/jmir.3177. Review.

18.

Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006).

Hjorth-Hansen H, Stenke L, Söderlund S, Dreimane A, Ehrencrona H, Gedde-Dahl T, Gjertsen BT, Höglund M, Koskenvesa P, Lotfi K, Majeed W, Markevärn B, Ohm L, Olsson-Strömberg U, Remes K, Suominen M, Simonsson B, Porkka K, Mustjoki S, Richter J; Nordic CML Study Group.

Eur J Haematol. 2015 Mar;94(3):243-50. doi: 10.1111/ejh.12423. Epub 2014 Sep 13.

19.

Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.

Vergès B, Adiels M, Boren J, Barrett PH, Watts GF, Chan D, Duvillard L, Söderlund S, Matikainen N, Kahri J, Robin I, Taskinen MR.

J Clin Endocrinol Metab. 2014 Nov;99(11):4281-90. doi: 10.1210/jc.2014-2365. Epub 2014 Jul 31.

PMID:
25077901
20.

Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome?

Richter J, Söderlund S, Lübking A, Dreimane A, Lotfi K, Markevärn B, Själander A, Saussele S, Olsson-Strömberg U, Stenke L.

J Clin Oncol. 2014 Sep 1;32(25):2821-3. doi: 10.1200/JCO.2014.55.6910. Epub 2014 Jul 28. No abstract available.

PMID:
25071107
21.

Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins.

Matikainen N, Adiels M, Söderlund S, Stennabb S, Ahola T, Hakkarainen A, Borén J, Taskinen MR.

Obesity (Silver Spring). 2014 Aug;22(8):1854-9. doi: 10.1002/oby.20781. Epub 2014 May 28.

22.

Forages and Pastures Symposium: development of and field experience with drought-tolerant maize.

Soderlund S, Owens FN, Fagan C.

J Anim Sci. 2014 Jul;92(7):2823-31. doi: 10.2527/jas.2013-7373. Epub 2014 Feb 4.

PMID:
24496836
23.

Genomic, transcriptomic, and lipidomic profiling highlights the role of inflammation in individuals with low high-density lipoprotein cholesterol.

Laurila PP, Surakka I, Sarin AP, Yetukuri L, Hyötyläinen T, Söderlund S, Naukkarinen J, Tang J, Kettunen J, Mirel DB, Soronen J, Lehtimäki T, Ruokonen A, Ehnholm C, Eriksson JG, Salomaa V, Jula A, Raitakari OT, Järvelin MR, Palotie A, Peltonen L, Oresic M, Jauhiainen M, Taskinen MR, Ripatti S.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):847-57. doi: 10.1161/ATVBAHA.112.300733. Epub 2013 Feb 14.

24.

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia.

Christiansson L, Söderlund S, Svensson E, Mustjoki S, Bengtsson M, Simonsson B, Olsson-Strömberg U, Loskog AS.

PLoS One. 2013;8(1):e55818. doi: 10.1371/journal.pone.0055818. Epub 2013 Jan 31.

25.

Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.

Adiels M, Matikainen N, Westerbacka J, Söderlund S, Larsson T, Olofsson SO, Borén J, Taskinen MR.

Atherosclerosis. 2012 May;222(1):222-8. doi: 10.1016/j.atherosclerosis.2012.02.001. Epub 2012 Feb 7.

PMID:
22365426
26.

Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects.

Taskinen MR, Adiels M, Westerbacka J, Söderlund S, Kahri J, Lundbom N, Lundbom J, Hakkarainen A, Olofsson SO, Orho-Melander M, Borén J.

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2144-50. doi: 10.1161/ATVBAHA.111.224808. Epub 2011 Jul 21.

27.

Effect of HDL composition and particle size on the resistance of HDL to the oxidation.

Shuhei N, Söderlund S, Jauhiainen M, Taskinen MR.

Lipids Health Dis. 2010 Sep 23;9:104. doi: 10.1186/1476-511X-9-104.

28.

Colitis-associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer.

Söderlund S, Tribukait B, Öst Å, Broström O, Karlén P, Löfberg R, Askling J, Sjöqvist U.

Inflamm Bowel Dis. 2011 May;17(5):1101-7. doi: 10.1002/ibd.21477. Epub 2010 Sep 17.

PMID:
20853434
29.

Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat.

Lundbom J, Hakkarainen A, Söderlund S, Westerbacka J, Lundbom N, Taskinen MR.

NMR Biomed. 2011 Apr;24(3):238-45. doi: 10.1002/nbm.1580. Epub 2010 Sep 6.

PMID:
20821410
30.

Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.

Yetukuri L, Söderlund S, Koivuniemi A, Seppänen-Laakso T, Niemelä PS, Hyvönen M, Taskinen MR, Vattulainen I, Jauhiainen M, Oresic M.

J Lipid Res. 2010 Aug;51(8):2341-51. doi: 10.1194/jlr.M006494. Epub 2010 Apr 29.

31.

Increased apolipoprotein E level and reduced high-density lipoprotein mean particle size associate with low high-density lipoprotein cholesterol and features of metabolic syndrome.

Söderlund S, Watanabe H, Ehnholm C, Jauhiainen M, Taskinen MR.

Metabolism. 2010 Oct;59(10):1502-9. doi: 10.1016/j.metabol.2010.01.015. Epub 2010 Mar 6.

PMID:
20206948
32.

Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

Söderlund S, Granath F, Broström O, Karlén P, Löfberg R, Ekbom A, Askling J.

Gastroenterology. 2010 May;138(5):1697-703. doi: 10.1053/j.gastro.2010.02.007. Epub 2010 Feb 16.

PMID:
20167217
33.

Characterizing human adipose tissue lipids by long echo time 1H-MRS in vivo at 1.5 Tesla: validation by gas chromatography.

Lundbom J, Hakkarainen A, Fielding B, Söderlund S, Westerbacka J, Taskinen MR, Lundbom N.

NMR Biomed. 2010 Jun;23(5):466-72. doi: 10.1002/nbm.1483.

PMID:
20099371
34.

Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias.

Naukkarinen J, Nilsson E, Koistinen HA, Söderlund S, Lyssenko V, Vaag A, Poulsen P, Groop L, Taskinen MR, Peltonen L.

Circ Cardiovasc Genet. 2009 Oct;2(5):522-9. doi: 10.1161/CIRCGENETICS.108.840421. Epub 2009 Jun 12.

35.

Intestinal flora in very low-birth weight infants.

Björkström MV, Hall L, Söderlund S, Håkansson EG, Håkansson S, Domellöf M.

Acta Paediatr. 2009 Nov;98(11):1762-7. doi: 10.1111/j.1651-2227.2009.01471.x. Epub 2009 Aug 8.

PMID:
19673724
36.

HDL subspecies in young adult twins: heritability and impact of overweight.

Pietiläinen KH, Söderlund S, Rissanen A, Nakanishi S, Jauhiainen M, Taskinen MR, Kaprio J.

Obesity (Silver Spring). 2009 Jun;17(6):1208-14. doi: 10.1038/oby.2008.675. Epub 2009 Feb 19.

37.

Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.

Söderlund S, Brandt L, Lapidus A, Karlén P, Broström O, Löfberg R, Ekbom A, Askling J.

Gastroenterology. 2009 May;136(5):1561-7; quiz 1818-9.

PMID:
19422077
38.

High prevalence of restless legs syndrome among patients with polycytemia vera treated with venesectio.

Tobiasson M, Alyass B, Söderlund S, Birgegård G.

Med Oncol. 2010 Mar;27(1):105-7. doi: 10.1007/s12032-009-9180-5. Epub 2009 Feb 19.

PMID:
19225914
39.

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity.

Nakanishi S, Vikstedt R, Söderlund S, Lee-Rueckert M, Hiukka A, Ehnholm C, Muilu M, Metso J, Naukkarinen J, Palotie L, Kovanen PT, Jauhiainen M, Taskinen MR.

J Lipid Res. 2009 Feb;50(2):183-92. doi: 10.1194/jlr.M800196-JLR200. Epub 2008 Sep 11.

40.

Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL.

Soro-Paavonen A, Naukkarinen J, Lee-Rueckert M, Watanabe H, Rantala E, Soderlund S, Hiukka A, Kovanen PT, Jauhiainen M, Peltonen L, Taskinen MR.

J Lipid Res. 2007 Jun;48(6):1409-16. Epub 2007 Mar 19.

41.

Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness.

Watanabe H, Söderlund S, Soro-Paavonen A, Hiukka A, Leinonen E, Alagona C, Salonen R, Tuomainen TP, Ehnholm C, Jauhiainen M, Taskinen MR.

Arterioscler Thromb Vasc Biol. 2006 Apr;26(4):897-902. Epub 2006 Feb 9.

42.

Colorectal cancer in colonic Crohn's disease--high frequency of DNA-aneuploidy.

Sjöqvist U, Befrits R, Söderlund S, Ost A, Karlén P, Tribukait B, Rubio C, Rutgeerts P, Geboes K, Löfberg R.

Anticancer Res. 2005 Nov-Dec;25(6C):4393-7.

43.

Hypertriglyceridemia is associated with prebeta-HDL concentrations in subjects with familial low HDL.

Söderlund S, Soro-Paavonen A, Ehnholm C, Jauhiainen M, Taskinen MR.

J Lipid Res. 2005 Aug;46(8):1643-51. Epub 2005 May 16.

44.

Effect of high-oil corn on growth performance, diet digestibility, and energy content of finishing diets fed to beef cattle.

Andrae JG, Hunt CW, Duckett SK, Kennington LR, Feng P, Owens FN, Soderlund S.

J Anim Sci. 2000 Sep;78(9):2257-62.

PMID:
10985396
45.
46.

Studies on metal content in the brown seaweed, Fucus vesiculosus, from the Archipelago of Stockholm.

Forsberg A, Söderlund S, Frank A, Petersson LR, Pedersén M.

Environ Pollut. 1988;49(4):245-63.

PMID:
15092658
48.

[The stage of pulmonary hypoplasia is crucial for survival in congenital diaphragmatic hernia].

Frenckner B, Ehrén H, Palmér K, Söderlund S.

Lakartidningen. 1986 Dec 24;83(52):4458-60. Swedish. No abstract available.

PMID:
3821303
49.

[Straw from the Christmas goat is an aspiration hazard for small children].

Frenckner B, Söderlund S.

Lakartidningen. 1983 Apr 20;80(16):1695. Swedish. No abstract available.

PMID:
6876966

Supplemental Content

Loading ...
Support Center